HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

about

The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG

P2860

Q40776497-0E96AA9D-1972-4A8C-8BA1-0271DA4832F8

P2860

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

Item

http://www.wikidata.org/entity/Q36249933

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

@ast

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

@en

type

Item

label

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

@ast

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

@en

prefLabel

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

@ast

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

@en

P1476

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

@en

P2093

Anshul Saxena

http://www.w3.org/2001/XMLSchema#string

Nancy Shehadeh

http://www.w3.org/2001/XMLSchema#string

Sandeep Appunni

http://www.w3.org/2001/XMLSchema#string

Venkataraghavan Ramamoorthy

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

A brief history of the global effort to develop a preventive HIV vaccine

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies

Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

P304

560347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1155/2015/560347

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Muni Rubens

P5008

ScienceSource

P577

2015-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283276453

http://www.w3.org/2001/XMLSchema#string

P698

26579546

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

globulins

blood proteins

P932

4633685

http://www.w3.org/2001/XMLSchema#string

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

about

P2860

P2860

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P5875

P698

P921

P932